It is recommended to take the tablets at a fixed time every day to establish a routine and improve the stability of efficacy
In the STEP-4 randomized trial (Rubino and colleagues, JAMA, 2021), the 803 adults who switched to placebo at week 20 regained about 6.9 percent of body weight over the next 48 weeks, while those who continued semaglutide kept losing
While GLP-1 and GIP receptor agonists are highly effective for initiating caloric deficits, human metabolism is highly adaptive
Providers routinely encounter patients who experience severe gastrointestinal intolerance, metabolic adaptation, or frustrating weight loss plateaus that render these first-line therapies insufficient
This article examines the evidence, appropriate clinical indications, potential risks, and NHS guidance on B12 treatment and weight management
Low blood sugar depends mainly on concurrent insulin or sulfonylurea use